SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-068915
Filing Date
2023-12-08
Accepted
2023-12-08 06:03:55
Documents
1
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_2023_agm_results.htm 6-K 51137
  Complete submission text file 0000950170-23-068915.txt   52228
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 231473855
SIC: 2835 In Vitro & In Vivo Diagnostic Substances